Trial intelligence / Profile preview

Remimazolam for general anesthesia in pediatric laparoscopic surgery

ChiCTR2500100534Phase 4Not yet recruiting

Sponsor
Qijiang Health Center for Maternal and Child Care
Start
Apr 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of remimazolam in inguinal hernia, hydrocele and appendicitis (3 arms), sponsored by Qijiang Health Center for Maternal and Child Care. Primary endpoint: Duration of extubation. Planned start Apr 2025; status: not yet recruiting.

02

Drugs

remimazolam
03

Conditions

inguinal herniahydroceleappendicitis

Beyond the preview

Go deeper on ChiCTR2500100534.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2500100534.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call